go-v.orgdoi

CRASH-2 - Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage

CRASH-2 Collaborators, · London School of Hygiene & Tropical Medicine · 2015

  • DOI 10.17037/data.10
  • Publisher London School of Hygiene & Tropical Medicine
  • Type dataset
  • Issued 2015

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

London School of Hygiene & Tropical Medicine · London School of Hygiene & Tropical Medicine · dataset · 2015

Abstract

A large randomised placebo controlled trial among trauma patients with or at risk of significant haemorrhage, of the effects of antifibrinolytic treatment on death and transfusion requirement. CRASH-2 is a randomised, controlled, double-blind trial undertaken in 274 hospitals in 40 countries. A total of 20211 adult trauma patients, with, or at risk of, significant bleeding (haemorrhage) were randomly assigned within 8 hours of injury to either tranexamic acid (TXA) or matching placebo.

The primary outcome was death in hospital within four weeks of injury and was described with the following categories: bleeding, vascular occlusion (myocardial infarction, stroke and pulmonary embolism), multiorgan failure, head injury, and other. This dataset is available at https://freebird.lshtm.ac.uk/index.php/data-sharing/downloads/crash2/

Open the resolved locator · 10.17037/data.10

Metadata licence: OpenAlex metadata (CC0)